Fakultni nemocnice Motol

Prague, Praha 5 150 06

0 studies enrolling now · 2 studies all time

What they study most

Crohn's Disease, Medullary Thyroid Cancer

Studies at this site

• A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer — Running, not enrolling
• A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Running, not enrolling